Table 2 Summary of treatment-related adverse events
From: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
Event | Grade 1 | Grade 2 |
|---|---|---|
n (%) | n (%) | |
Fatigue | 1 (11) | 0 |
Flu-like symptoms | 6 (67) | 2 (22) |
Injection site reaction | 7 (78) | 2 (22) |
Malaise | 1 (11) | 0 |
Increased alanine aminotransferase | 1 (11) | 0 |
Decrease white blood cell count | 2 (22) | 0 |
Decreased neutrophil count | 1 (11) | 0 |
Dry skin | 1 (11) | 0 |
